Social determinants of health (SDOH) influence inequities in systemic lupus erythematosus (SLE). While these inequities contribute to overall disease experience, there is little consensus guiding our understanding of the psychological implications of SDOH in SLE. Given the paucity of evidence in this area, the aim of this scoping review was to systematically assess the volume and features of available research literature on associations of SDOH with depression in SLE over the past 20 years, from 1 January 2000 to 16 November 2021. We developed a search strategy for PubMed and EMBASE that included keywords for depression and lupus. After screening 2188 articles, we identified 22 original articles that met our inclusion criteria. At least one SDOH was associated with depression in two of the six studies with unadjusted estimates and 13 of the 16 studies with adjusted estimates. Results provide consistent but sparse evidence that SDOH are associated with depression in SLE. Additionally, depression epidemiology in SLE may differ from the general population such that depression risk is more similar across genders and racial/ethnic groups. More work is needed to identify the SDOH that have the greatest impact on depression and mental health among SLE patients, as well as how and when to intervene.
Get full access to this article
View all access options for this article.
References
1.
Pons-EstelGJAlarcónGSScofieldL, et al.Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum2010; 39(4): 257–268.
2.
GómezCAKleinmanDVPronkN, et al.Addressing health equity and social determinants of health through healthy people 2030. J Public Health Manag Pract2021; 27(6): S249–S257.
3.
BaileyZDKriegerNAgénorM, et al.Structural racism and health inequities in the USA: evidence and interventions. The Lancet2017; 389(10077): 1453–1463.
4.
HarnoisCEBastosJL. Discrimination, harassment, and gendered health inequalities: do perceptions of workplace mistreatment contribute to the gender gap in self-reported health?J Health Soc Behav2018; 59(2): 283–299.
5.
DeQuattroKYelinE. Socioeconomic status, health care, and outcomes in systemic lupus erythematosus. Rheum Dis Clin2020; 46(4): 639–649.
6.
FeldmanCHHirakiLTLiuJ, et al.Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000–2004. Arthritis Rheum2013; 65(3): 753–763.
7.
Gómez-PuertaJABarbhaiyaMGuanH, et al.Racial/ethnic variation in all-cause mortality among United States Medicaid recipients with systemic lupus erythematosus: a hispanic and asian paradox. Arthritis Rheumatol2015; 67(3): 752–760.
8.
AlarcónGSMcGwinGSanchezML, et al.Systemic lupus erythematosus in three ethnic groups. XIV. Poverty, wealth, and their influence on disease activity. Arthritis Rheum2004; 51(1): 73–77.
9.
MccormickNTrupinLYelinEH, et al.Socioeconomic predictors of incident depression in systemic lupus erythematosus. Arthritis Care Res2018; 70(1): 104–113.
10.
ParkDJKangJHLeeKE, et al.Association of depression with socioeconomic status, anticardiolipin antibodies, and organ damage in patients with systemic lupus erythematosus: results from the KORNET registry. Clin Exp Rheumatol2018; 36(4): 627–635.
11.
HuangXMagderLSPetriM. Predictors of incident depression in systemic lupus erythematosus. J Rheumatol2014; 41(9): 1823–1833.
12.
TrupinLTonnerMCYazdanyJ, et al.The role of neighborhood and individual socioeconomic status in outcomes of systemic lupus erythematosus. J Rheumatol2008; 35(9): 1782–1788.
13.
JulianLJYelinEYazdanyJ, et al.Depression, medication adherence, and service utilization in systemic lupus erythematosus. Arthritis Care Res2009; 61(2): 240–246.
14.
SumnerLAOlmsteadRAzizoddinDR, et al.The contributions of socioeconomic status, perceived stress, and depression to disability in adults with systemic lupus erythematosus. Disabil Rehabil2020; 42(9): 1264–1269.
CepoiuMMcCuskerJColeMG, et al.Recognition of depression by non-psychiatric physicians—a systematic literature review and meta-analysis. J Gen Intern Med2008; 23(1): 25–36.
17.
MachinAHiderSDaleN, et al.Improving recognition of anxiety and depression in rheumatoid arthritis: a qualitative study in a community clinic. Br J Gen Pract2017; 67(661): e531–e537.
18.
ShimRSComptonMT. The social determinants of mental health: psychiatrists’ roles in addressing discrimination and food insecurity. FOCUS2020; 18(1): 25–30.
19.
AlegríaMNeMoyerAFalgàs BaguéI, et al.Social determinants of mental health: where we are and where we need to go. Curr Psychiatry Rep2018; 20(11): 95.
20.
DaleEBang-AndersenBSánchezC. Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochem Pharmacol2015; 95(2): 81–97.
21.
MarmotMGSmithGDStansfeldS, et al.Health inequalities among British civil servants: the Whitehall II study. Lancet Lond Engl1991; 337(8754): 1387–1393.
22.
AndermannA. Taking action on the social determinants of health in clinical practice: a framework for health professionals. CMAJ Can Med Assoc J2016; 188(17–18): E474–E483.
23.
FeldmanCHRamsey-GoldmanR. Widening disparities among patients with rheumatic diseases in the COVID-19 era: an urgent call to action. Arthritis Rheumatol2020; 72(9): 1409–1411.
24.
GrantMJBoothA. A typology of reviews: an analysis of 14 review types and associated methodologies. Health Inf Libr J2009; 26(2): 91–108.
25.
TriccoACLillieEZarinW, et al.PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med2018; 169(7): 467–473.
26.
ShenBTanWFengG, et al.The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Dev Immunol2013; 2013: 270878.
27.
DietzBKatzPDall’EraM, et al.Major depression and adverse patient-reported outcomes in systemic lupus erythematosus: results from a prospective longitudinal cohort. Arthritis Care Res2021; 73(1): 48–54.
28.
PanopalisPJulianLYazdanyJ, et al.Impact of memory impairment on employment status in persons with systemic lupus erythematosus. Arthritis Care Res2007; 57(8): 1453–1460.
29.
JulianLJTonnerCYelinE, et al.Cardiovascular and disease-related predictors of depression in systemic lupus erythematosus. Arthritis Care Res2011; 63(4): 542–549.
30.
KnightAMTrupinLKatzP, et al.Depression risk in young adults with juvenile- and adult-onset lupus: twelve years of followup. Arthritis Care Res2018; 70(3): 475–480.
31.
PattersonSLTrupinLYazdanyJ, et al.Physical inactivity independently predicts incident depression in a multi-racial/ethnic systemic lupus cohort. Arthritis Care Res2021; 74(7). [Internet]. [cited 2021 Dec 21];n/a(n/a). Available from:http://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24555
32.
XieXWuDChenH. Prevalence and risk factors of anxiety and depression in patients with systemic lupus erythematosus in Southwest China. Rheumatol Int2016; 36(12): 1705–1710.
33.
AlsowaidaNAlrasheedMMayetA, et al.Medication adherence, depression and disease activity among patients with systemic lupus erythematosus. Lupus2018; 27(2): 327–332.
34.
Al-HomoodIAOmranNEAlwahibiAS, et al.Depression in patients with systemic lupus erythematosus: a multicenter study. Saudi J Med Med Sci2017; 5(3): 248–253.
35.
JorgeALertratanakulALeeJ, et al.Depression and progression of subclinical cardiovascular disease in systemic lupus erythematosus. Arthritis Care Res2017; 69(1): 5–11.
36.
KarimifarMSharifiIShafieyK. Anti-ribosomal P antibodies related to depression in early clinical course of systemic lupus erythematosus. J Res Med Sci Off J Isfahan Univ Med Sci2013; 18(10): 860–864.
37.
PetriMNaqibuddinMCarsonKA, et al.Depression and cognitive impairment in newly diagnosed systemic lupus erythematosus. J Rheumatol2010; 37(10): 2032–2038.
38.
AndersonEWFishbeinJHongJ, et al.Quinolinic acid, a kynurenine/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus. Lupus Sci Med2021; 8(1): e000559.
39.
EldeiryDZandyMTayer-ShifmanOE, et al.Association between depression and anxiety with skin and musculoskeletal clinical phenotypes in systemic lupus erythematosus. Rheumatol Oxf Engl2020; 59(11): 3211–3220.
40.
VinaERHausmannLRMUtsetTO, et al.Perceptions of racism in healthcare among patients with systemic lupus erythematosus: a cross-sectional study. Lupus Sci Med2015; 2(1): e000110.
41.
CrosslinKLWigintonKL. Sex differences in disease severity among patients with systemic lupus erythematosus. Gend Med2011; 8(6): 365–371.
42.
IshikuraRMorimotoNTanakaK, et al.Factors associated with anxiety, depression and suicide ideation in female outpatients with SLE in Japan. Clin Rheumatol2001; 20(6): 394–400.
43.
KnightAMXieMMandellDS. Disparities in psychiatric diagnosis and treatment for youth with systemic lupus erythematosus: analysis of a national US Medicaid sample. J Rheumatol2016; 43(7): 1427–1433.
44.
HasinDSSarvetALMeyersJL, et al.Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry2018; 75(4): 336–346.
45.
Chapter: 4 assessing potential sources of racial and ethnic disparities in care: the clinical encounter, StithAYNelsonAR (eds). Washington DC: National Academies Press (US), 2003.Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care
46.
MacêdoEAAppenzellerSCostallatLTL. Depression in systemic lupus erythematosus: gender differences in the performance of the Beck depression inventory (BDI), center for epidemiologic studies depression Scale (CES-D), and hospital anxiety and depression Scale (HADS). Lupus2018; 27(2): 179–189.
47.
BergmansRSZivinKMezukB. Depression, food insecurity and diabetic morbidity: evidence from the health and retirement study. J Psychosom Res2019; 117: 22–29.
48.
HarariLLeeC. Intersectionality in quantitative health disparities research: a systematic review of challenges and limitations in empirical studies. Soc Sci Med2021; 277: 113876.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
